[go: up one dir, main page]

MX2010006446A - Nuevos derivados de diazeniodiolato, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen. - Google Patents

Nuevos derivados de diazeniodiolato, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.

Info

Publication number
MX2010006446A
MX2010006446A MX2010006446A MX2010006446A MX2010006446A MX 2010006446 A MX2010006446 A MX 2010006446A MX 2010006446 A MX2010006446 A MX 2010006446A MX 2010006446 A MX2010006446 A MX 2010006446A MX 2010006446 A MX2010006446 A MX 2010006446A
Authority
MX
Mexico
Prior art keywords
preparation
same
pharmaceutical compositions
compositions containing
group
Prior art date
Application number
MX2010006446A
Other languages
English (en)
Inventor
Tony Verbeuren
Christine Courchay
Serge Simonet
Alexis Cordi
Laure Haberkorn
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MX2010006446A publication Critical patent/MX2010006446A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compuestos de la fórmula (I), en los cuales: R1 representa un átomo de hidrógeno o un grupo -COOR, R2 representa un grupo G o un grupo alquilo de (C1-C6) lineal o ramificado sustituido por un grupo G, donde G representa un grupo -(CH2)n-A(CH2)m-B-(CR4R5)p-(C H2)o-R6 como se definió en la descripción, y R3 representa un átomo de hidrógeno, un grupo alquilo o un grupo NO2.
MX2010006446A 2007-12-11 2008-12-10 Nuevos derivados de diazeniodiolato, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen. MX2010006446A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0708604A FR2924713B1 (fr) 2007-12-11 2007-12-11 Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2008/001716 WO2009103875A1 (fr) 2007-12-11 2008-12-10 Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
MX2010006446A true MX2010006446A (es) 2010-07-05

Family

ID=39158541

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010006446A MX2010006446A (es) 2007-12-11 2008-12-10 Nuevos derivados de diazeniodiolato, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.

Country Status (26)

Country Link
US (1) US8288433B2 (es)
EP (1) EP2231598B1 (es)
JP (1) JP5247814B2 (es)
KR (1) KR20100083195A (es)
CN (1) CN101910128B (es)
AR (1) AR069643A1 (es)
AT (1) ATE520658T1 (es)
AU (1) AU2008351147B2 (es)
BR (1) BRPI0822066A2 (es)
CA (1) CA2707853C (es)
DK (1) DK2231598T3 (es)
EA (1) EA201000885A1 (es)
ES (1) ES2371699T3 (es)
FR (1) FR2924713B1 (es)
GE (1) GEP20135733B (es)
HR (1) HRP20110755T1 (es)
MA (1) MA31901B1 (es)
MX (1) MX2010006446A (es)
MY (1) MY147973A (es)
NZ (1) NZ586070A (es)
PL (1) PL2231598T3 (es)
PT (1) PT2231598E (es)
RS (1) RS52001B (es)
SI (1) SI2231598T1 (es)
UA (1) UA97035C2 (es)
WO (1) WO2009103875A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011053519A1 (en) * 2009-10-29 2011-05-05 Merck Sharp & Dohme Corp. Diuretics
BR112012019169A2 (pt) 2010-02-12 2018-02-06 Merck Sharp & Dohme composto, composição farmacêutica, e, uso da mesma
US8623846B2 (en) 2010-05-21 2014-01-07 Merck Sharp & Dohme Corp. Diazeniumdiolate cyclohexyl derivatives
AU2011320595A1 (en) 2010-10-29 2013-06-06 Merck Sharp & Dohme Corp. Diazeniumdiolate heterocyclic derivatives
JO3350B1 (ar) * 2011-03-07 2019-03-13 Merck Sharp & Dohme مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات
US9272987B2 (en) 2011-05-02 2016-03-01 Merck Sharp & Dohme Corp. Diazeniumdiolate cyclohexyl derivatives
CN109608371B (zh) * 2019-01-16 2020-12-29 泰州学院 O2-4-(3-(4-胺磺酰基苯基)脲)苯基偶氮鎓二醇盐衍生物、制备方法及用途
CN114805183B (zh) * 2022-05-07 2022-12-27 武汉科技大学 一类no供体型荜茇酰胺衍生物、制备方法及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203691A (en) * 1968-03-06 1970-09-03 Science Union & Cie New disubstituted n-amino indoline derivatives and process for preparing them
JPH0233030B2 (ja) * 1982-01-18 1990-07-25 Mitsui Toatsu Chemicals Surufuamoiruansokukosanjudotaioyobisoreojukoseibuntoshitefukumuchiryoyososeibutsu
JPH07118231A (ja) * 1993-10-22 1995-05-09 Nippon Oil & Fats Co Ltd スルファモイル安息香酸誘導体
US5958427A (en) * 1996-11-08 1999-09-28 Salzman; Andrew L. Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
AUPS236902A0 (en) * 2002-05-16 2002-06-13 Northern Sydney Area Health Service Composition and method for treating hypertension
WO2006055542A2 (en) * 2004-11-15 2006-05-26 Nitromed, Inc. Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
CA2597460A1 (en) * 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
US7947664B2 (en) * 2008-01-24 2011-05-24 Merck Sharp & Dohme Corp. Angiotensin II receptor antagonists
AU2009210484A1 (en) * 2008-02-08 2009-08-13 Merck Sharp & Dohme Corp. Angiotensin II receptor antagonists

Also Published As

Publication number Publication date
FR2924713B1 (fr) 2010-01-29
EP2231598B1 (fr) 2011-08-17
AU2008351147A1 (en) 2009-08-27
FR2924713A1 (fr) 2009-06-12
AR069643A1 (es) 2010-02-10
ATE520658T1 (de) 2011-09-15
BRPI0822066A2 (pt) 2015-09-22
EA201000885A1 (ru) 2011-02-28
MY147973A (en) 2013-02-28
PL2231598T3 (pl) 2011-12-30
PT2231598E (pt) 2011-10-11
EP2231598A1 (fr) 2010-09-29
ES2371699T3 (es) 2012-01-09
AU2008351147B2 (en) 2012-04-12
RS52001B (sr) 2012-04-30
MA31901B1 (fr) 2010-12-01
CA2707853C (fr) 2013-02-05
GEP20135733B (en) 2013-01-25
WO2009103875A1 (fr) 2009-08-27
SI2231598T1 (sl) 2011-11-30
JP2011506408A (ja) 2011-03-03
CA2707853A1 (fr) 2009-08-27
KR20100083195A (ko) 2010-07-21
DK2231598T3 (da) 2011-12-05
CN101910128A (zh) 2010-12-08
NZ586070A (en) 2012-06-29
HRP20110755T1 (hr) 2011-11-30
US20100286225A1 (en) 2010-11-11
US8288433B2 (en) 2012-10-16
UA97035C2 (ru) 2011-12-26
JP5247814B2 (ja) 2013-07-24
CN101910128B (zh) 2013-01-16

Similar Documents

Publication Publication Date Title
MX2010006446A (es) Nuevos derivados de diazeniodiolato, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
MX2012004453A (es) Composicion para el control de plagas.
CY1114836T1 (el) Παραγωγο δικυκλικου γ-αμινοξεος
GEP20135948B (en) Isoxazole derivatives for use as plant growth regulators
WO2009022687A1 (ja) フェニル酢酸化合物
CU24030B1 (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen
WO2008107502A8 (es) Composicion para el tratamiento de enfermedades infecciosas
PT2280706E (pt) Composições compreendendo derivados de benzeno que activam lipase de lipoproteína
TW200744659A (en) Preparation for preventing and ameliorating wrinkle
CY1115623T1 (el) Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
MX2008016558A (es) Preparacion y aplicacion terapéutica de derivados de 2-benzoil-imidazopiridinas.
MY183326A (en) New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
WO2007144512A3 (fr) Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires
MY146939A (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
UA105022C2 (uk) Композиція для боротьби з хворобами рослин та спосіб боротьби з хворобами рослин
MX2010001081A (es) Derivados de 1-oxo-1,2-dihidroisoquinolina-5-carboxamidas y de 4-oxo-3,4-dihidroquinazolina-8-carboxamidas, su preparacion y su uso terapeutico.
WO2009005135A1 (ja) エポキシ樹脂用硬化剤及びエポキシ樹脂用硬化剤組成物
MX2010008448A (es) Compuesto de bencilpiperizina.
WO2011009075A3 (en) Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
WO2009004164A3 (fr) Derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1946743A3 (en) Humectant composition
MX2009005880A (es) Ciclohexenil-butenonas y composiciones de fragancia que las comprenden.
BRPI0514792A (pt) composto, utilização de um composto e composição farmacêutica
TW200700419A (en) 5,6-dialkyl-7-aminoazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds

Legal Events

Date Code Title Description
FG Grant or registration